Tags - flue

Young journalists club

Tags - flue
Japanese regulators considered data from a first late-stage trial in making their decision. Xofluza, which was developed in 2015, is the first drug to be approved through the fast-track review system, the Nikkei Asian Review reported.
News ID: 19769    Publish Date : 2018/02/24